MedPath

Reconstruction of Hand Soft Tissue Defects

Not Applicable
Conditions
Hand Injuries
Interventions
Procedure: Posterior interosseous artery flap
Registration Number
NCT05218252
Lead Sponsor
Sohag University
Brief Summary

Evaluation of distally based posterior interosseous artery flap in reconstructing hand soft tissue defects that may result from trauma, extensive burns, tumor resection or congenital deformities.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
15
Inclusion Criteria
  1. Patients with complex defects over the dorsal and palmar aspect of the wrist and the hand up to the proximal interphalangeal joint level, the whole thumb, and the first web space.
  2. Small to moderate hand defects resulting from post-traumatic raw areas, post-traumatic deformities, postburn deformities and scar, post tumor resection, and congenital hand deformity.
  3. Availability of a healthy donor site.
Exclusion Criteria
  1. Patients with a major uncontrollable medical illness.
  2. Chronic heavy smokers.
  3. Traumatic injury to the donor site.
  4. Complex defects of the hand beyond the PIP joint level.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Hand soft tissue defectsPosterior interosseous artery flapPatients with mild to moderate hand soft tissue defects with exposed bone, tendons or cartilage resulting from trauma, tumor ablation or postburn deformities.
Primary Outcome Measures
NameTimeMethod
Functional and aesthetic outcomes of posterior interosseous artery flap5 months from the end of treatment

All patients will be evaluated with objective (functional) and subjective (aesthetic) criteria. Hand functionality will be evaluated using the disability of the arm, shoulder, and hand (DASH) score. The DASH score comprises 30 questions, and the score ranges from 30 points, for no limitation, to 150 points, for maximum limitation.

The outcomes will be aesthetically reviewed with scar assessment measured as being good, fair, and poor. This assessment is subjective. Donor site problems are identified as cold intolerance, numbness, and pain. These will be evaluated as being either present in the patient or non-existent.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sohag University Hospital

🇪🇬

Sohag, Egypt

© Copyright 2025. All Rights Reserved by MedPath